SUNLIGHT: New Standard of Care in Refractory Metastatic CRC SUNLIGHT: New Standard of Care in Refractory Metastatic CRC

The SUNLIGHT trial results show that adding bevacizumab to trifluridine/tipiracil (Lonsurf) improves median overall and progression free survival without increasing the risk for serious adverse events.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news